Altered baseline cerebral blood flow and neurotransmitter levels in episodic and chronic migraine
Lars Michels1, Franz Riederer2,3, Jeanette Villanueva1, Andreas Gantenbein4, Peter Sandor4, Roger Luechinger5, Martin Wilson6, and Spyros Kollias1

1University Hospital Zurich, Zurich, Switzerland, 2Neurological Center Rosenhuegel and Karl Landsteiner Institute for Epilepsy Research and Cognitive Neurology, Vienna, Austria, 3University of Zurich, Zurich, Switzerland, 4RehaClinic, Bad Zurzach & Baden, Switzerland, 5Swiss Federal Institute of Technology, Zurich, Switzerland, 6University of Birmingham, Birmingham, United Kingdom

Synopsis

Although it has been described that cerebral blood flow and cortical excitability is altered in migraineurs, it is unknown if these processes may be differentially involved in chronic and episodic forms of the disease. We used arterial spin labeling MRI und magnetic resonance spectroscopy (GABA-editing) to address this problem. We found lower levels of combined glutamate and glutamine in chronic and episodic migraineurs relative to controls. Chronic patients showed hypoperfusion relative to controls and episodic migraineurs. Our results might indicate severe signs of cortical spreading depression in chronic migraineurs. The MRS findings suggest a disturbed excitation-inhibition balance in migraineurs.

Audience

People that are interested in metabolic changes in migraine

Introduction

Based on the available literature 1-3, altered cerebral blood flow (CBF) has been observed during migraine attacks and changes in cortical excitability have been described. Yet, it is unknown if these processes may be differentially involved in chronic and episodic forms of the disease.

Methods

We examined 16 adult patients with episodic (EM, 2 males) and 21 with chronic migraine (CM, 6 males) as well as 26 healthy controls (HC, 10 males). We recorded attack frequency, pain intensity, aura occurrence and medication. To assess baseline CBF (during the interictal period), we used non-invasive arterial spin labeling magnetic resonance imaging (ASL-MRI). Specifically, CBF was recorded with a 2D pseudo-continuous ASL (pCASL) sequence 4 with background suppression (repetition time (TR)/echo time (TE) = 4200/16 ms, flip angle: 90°, voxel size: 3 x 3 mm, 20 slices, thickness: 6 mm, labeling duration: 1.65 s, post-labeling delay: 1.53 s) implemented on a Philips 3 Tesla Ingenia scanner. Equilibrium brain tissue magnetization (M0) images were recorded too. The ASL analysis was performed with the ASL toolbox 5. Pre-processing included motion correction, spatial smoothing and normalization. CBF quantification was done using the one-compartment model 6. CBF difference images were achieved by simple subtraction to minimize spurious BOLD contaminations within the CBF signal 7. We assessed main effects of group with an analysis of variance (ANOVA). Next, we calculated planned contrasts (t-tests, p < 0.001) between groups. For magnetic resonance spectroscopy (MRS) imaging, we used MEGA-PRESS 8, 9 to asses both GABA (inhibition) and Glx (combined glutamate and glutamine: excitation). MEGA editing was combined with the Point-Resolved Spectroscopy Sequence, inner volume saturation (Henning et al., 2008), and interleaved “VAPOR” water suppression 10, 11. MEGA-PRESS with inner volume saturation increases sensitivity for edited single-voxel measurements of glutamate and GABA 8. We recorded ten blocks (320 averages total) and per block, the editing pulse was applied in an alternating manner either at 1.9 ppm or at 7.5 ppm. All blocks were retrospectively frequency aligned using the Choline and Creatine as frequency references. The radio frequency carrier frequency was set to Creatine. MRS parameters were: TR/TE: 1800 ms/68 ms, editing pulse duration: 16 ms. We recorded MRS from a voxel covering the bilateral visual cortex (30 x 30 x 30 mm), positioned on a T1-weighted 3D-MPRAGE image. The analysis was performed with TARQUIN (Wilson et al., 2011) that yields comparable reliability in metabolite concentration estimates to LCModel 12-14. Spectral quality was assessed using Cramer-Rao lower bounds (CRLB); data with a CRLB > 20% were considered unreliable. The reference signal was set to H2O (= H2O scaled). Metabolite-to-H2O ratios were corrected for differences in grey- and white matter, and cerebrospinal fluid voxel content, influencing the measured H2O concentration 15. The resulting metabolite-to-H2O ratios are presented in institutional units (IU).

Results

Participants did not differ with respect to sex, age, and handedness. Pain scores (during MRI), depression and anxiety values were not different between the two patient groups. For CBF, a main effect of group was seen (F(3, 60) = 8.4, p < 0.001). EM revealed lower CBF than HC in fronto-central brain regions, including the striatum (Fig. 1A). In contrast, EM showed stronger CBF in the brainstem (Fig. 1B). The contrast ‘HC - CM’ yielded widespread hypoperfusion in frontal, somatosensory, parietal, temporal, cerebellar, and visual regions in CM (Fig 1C). EM demonstrated higher CBF than CM in visual, parietal, thalamic, cerebellar, temporal, orbito- and inferior frontal regions (Fig. 1D). Glx was reduced in CM (p = 0.002) and EM (p = 0.036) relative to HC (Figure 2). GABA was higher in the EM than CM group (p = 0.041). Headache days were not linked to levels of GABA or Glx within or across patient groups.

Discussion and Conclusion

CBF changes in migraineurs are observable in areas linked to pain processing such as the anterior cingulate and insular cortex, thalamus, and brainstem. CM showed even lower CBF relative to EM in visual areas, which might be linked to more severe signs of cortical spreading depression in chronically affected patients. Based on the MRS findings, we conclude that cortical excitability is altered during interictal periods in EM and CM, and that the excitation-inhibition balance is especially disturbed in CM, as not only Glx but also GABA is altered. However, it needs to be examined if it is glutamine and/or glutamate that are lowered in migraineurs.

Acknowledgements

We thank the Hansruedi Isler foundation for financial support.

References

1. Aguila, M.E., et al. Elevated levels of GABA+ in migraine detected using (1) H-MRS. NMR in biomedicine 28, 890-897 (2015). 2. Pollock, J.M., et al. Migraine associated cerebral hyperperfusion with arterial spin-labeled MR imaging. AJNR. American journal of neuroradiology 29, 1494-1497 (2008). 3. May, A. New insights into headache: an update on functional and structural imaging findings. Nature reviews. Neurology 5, 199-209 (2009). 4. Wong, E.C., Buxton, R.B. & Frank, L.R. Implementation of quantitative perfusion imaging techniques for functional brain mapping using pulsed arterial spin labeling. NMR in biomedicine 10, 237-249 (1997). 5. Wang, Z., et al. Empirical optimization of ASL data analysis using an ASL data processing toolbox: ASLtbx. Magn Reson Imaging 26, 261-269 (2008). 6. Buxton, R.B., et al. A general kinetic model for quantitative perfusion imaging with arterial spin labeling. Magnetic resonance in medicine : official journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine 40, 383-396 (1998). 7. Liu, T.T. & Wong, E.C. A signal processing model for arterial spin labeling functional MRI. Neuroimage 24, 207-215 (2005). 8. Edden, R.A. & Barker, P.B. Spatial effects in the detection of gamma-aminobutyric acid: improved sensitivity at high fields using inner volume saturation. Magn Reson Med 58, 1276-1282 (2007). 9. Puts, N.A. & Edden, R.A. In vivo magnetic resonance spectroscopy of GABA: a methodological review. Prog Nucl Magn Reson Spectrosc 60, 29-41 (2012). 10. Hock, A., Fuchs, A., Boesiger, P., Kollias, S.S. & Henning, A. Electrocardiogram-triggered, higher order, projection-based B(0) shimming allows for fast and reproducible shim convergence in spinal cord (1)H MRS. NMR in biomedicine 26, 329-335 (2013). 11. Tkac, I., Starcuk, Z., Choi, I.Y. & Gruetter, R. In vivo 1H NMR spectroscopy of rat brain at 1 ms echo time. Magn Reson Med 41, 649-656 (1999). 12. Mullins, P.G., et al. Current practice in the use of MEGA-PRESS spectroscopy for the detection of GABA. NeuroImage 86, 43-52 (2014). 13. Provencher, S.W. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med 30, 672-679 (1993). 14. Wilson, M., Reynolds, G., Kauppinen, R.A., Arvanitis, T.N. & Peet, A.C. A constrained least-squares approach to the automated quantitation of in vivo (1)H magnetic resonance spectroscopy data. Magn Reson Med 65, 1-12 (2011). 15. Gasparovic, C., et al. Use of tissue water as a concentration reference for proton spectroscopic imaging. Magn Reson Med 55, 1219-1226 (2006).

Figures

Summary of ASL-MRI results. Patients with (A) EM and (C) CM demonstrated hypoperfusion in several brain regions relative to HC. Results are shown at a voxel-threshold of p < 0.001. EM showed (B) hyperperfusion in the brainstem relative to HC and (D) stronger CBF than CM. EM: episodic migraine, CM: chronic migraine, HC: healthy controls.

Summary of MRS results. GABA was lower in CM than in EM. CM and EM revealed lower levels of combined glutamate and glutamine (Glx) than HC. GABA and Glx values are given in institutional units (IU). *p < 0.05 and **p < 0.01. EM: episodic migraine, CM: chronic migraine, HC: healthy controls.



Proc. Intl. Soc. Mag. Reson. Med. 24 (2016)
1427